Center for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, China.
Biomaterials. 2013 Aug;34(25):6046-57. doi: 10.1016/j.biomaterials.2013.04.055. Epub 2013 May 20.
The repair of osteochondral defects can be enhanced with scaffolds but is often accompanied with undesirable terminal differentiation of bone marrow-derived mesenchymal stem cells (BMSCs). Parathyroid hormone-related protein (PTHrP) has been shown to inhibit aberrant differentiation, but administration at inappropriate time points would have adverse effects on chondrogenesis. This study aims to develop an effective tissue engineering strategy by combining PTHrP and collagen-silk scaffold for osteochondral defect repair. The underlying mechanisms of the synergistic effect of combining PTHrP administration with collagen-silk scaffold implantation for rabbit knee joint osteochondral defect repair were investigated. In vitro studies showed that PTHrP treatment significantly reduced Alizarin Red staining and expression of terminal differentiation-related markers. This is achieved in part through blocking activation of the canonical Wnt/β-catenin signaling pathway. For the in vivo repair study, intra-articular injection of PTHrP was carried out at three different time windows (4-6, 7-9 and 10-12 weeks) together with implantation of a bi-layer collagen-silk scaffold. Defects treated with PTHrP at the 4-6 weeks time window exhibited better regeneration (reconstitution of cartilage and subchondral bone) with minimal terminal differentiation (hypertrophy, ossification and matrix degradation), as well as enhanced chondrogenesis (cell shape, Col2 and GAG accumulation) compared with treatment at other time windows. Furthermore, the timing of PTHrP administration also influenced PTHrP receptor expression, thus affecting the treatment outcome. Our results demonstrated that intra-articular injection of PTHrP at 4-6 weeks post-injury together with collagen-silk scaffold implantation is an effective strategy for inhibiting terminal differentiation and enhancing chondrogenesis, thus improving cartilage repair and regeneration in a rabbit model.
骨软骨缺损的修复可以通过支架来增强,但往往伴随着骨髓间充质干细胞(BMSCs)的不可控终末分化。甲状旁腺激素相关蛋白(PTHrP)已被证明可以抑制异常分化,但在不合适的时间点给药会对软骨形成产生不利影响。本研究旨在通过将 PTHrP 与胶原-丝素支架相结合,开发一种有效的组织工程策略,用于骨软骨缺损修复。研究了联合应用 PTHrP 给药和胶原-丝素支架植入修复兔膝关节骨软骨缺损的协同作用的潜在机制。体外研究表明,PTHrP 处理显著减少茜素红染色和终末分化相关标志物的表达。这部分是通过阻断经典 Wnt/β-catenin 信号通路的激活来实现的。在体内修复研究中,在三个不同的时间窗(4-6、7-9 和 10-12 周)联合应用双层胶原-丝素支架,对关节内注射 PTHrP。与其他时间窗相比,在 4-6 周时间窗接受 PTHrP 治疗的缺陷表现出更好的再生(软骨和软骨下骨的重建),最小的终末分化(肥大、骨化和基质降解),以及增强的软骨形成(细胞形状、Col2 和 GAG 积累)。此外,PTHrP 给药的时间也影响 PTHrP 受体的表达,从而影响治疗效果。我们的结果表明,在损伤后 4-6 周关节内注射 PTHrP 联合胶原-丝素支架植入是一种抑制终末分化和增强软骨形成的有效策略,从而改善兔模型中的软骨修复和再生。